Premium Eluxadoline API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Eluxadoline (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Mixed Mu-Opioid Receptor Agonist / Delta-Opioid Receptor Antagonist

Indications: Irritable Bowel Syndrome with Diarrhea (IBS-D)

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Eluxadoline distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Eluxadoline is a highly specialized, locally acting small-molecule Active Pharmaceutical Ingredient (API). In gastroenterological pharmacology, it is utilized as a novel neuromodulator of the enteric nervous system, specifically engineered for the management of chronic functional gastrointestinal disorders.

Unlike standard anti-diarrheal agents, Eluxadoline features a complex, multi-targeted receptor binding profile. It acts simultaneously as an agonist at the mu-opioid receptor (MOR) and kappa-opioid receptor (KOR), while functioning as an antagonist at the delta-opioid receptor (DOR).

In the pathophysiology of Irritable Bowel Syndrome with Diarrhea (IBS-D), accelerated gastrointestinal transit and visceral hypersensitivity are the primary drivers of patient morbidity. The MOR agonism slows intestinal motility, effectively reducing diarrhea. Conversely, the simultaneous DOR antagonism mitigates the severe, iatrogenic constipation that frequently occurs with unopposed MOR agonists (such as loperamide). Furthermore, because Eluxadoline exhibits extremely low systemic bioavailability, its pharmacological activity is restricted almost entirely to the gastrointestinal tract, avoiding the central nervous system (CNS) effects typically associated with opioid receptor modulators.

For formulation scientists, integrating this API allows for the development of highly specific, localized gastrointestinal therapeutics. In commercial manufacturing, Eluxadoline is standardly formulated into 75 mg and 100 mg oral solid tablets for adult patients.

Sourcing Eluxadoline in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced gastroenterology formulations requires a highly resilient and traceable raw material pipeline. Procuring specialized, multi-receptor APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. Sourcing Eluxadoline Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard pilot batch or are scaling up a high-volume Eluxadoline api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during blending, wet granulation, and tablet compression processes.

Technical Specifications for QA & R&D

The Eluxadoline API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: 5-({[2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)-propanoyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxybenzoic acid
• CAS Number: 864821-90-9
• Appearance: White to off-white crystalline solid powder
• Molecular Formula: C32H35N5O5
• Molecular Weight: 569.65 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Eluxadoline is practically insoluble in water and exhibits pH-dependent solubility. Detailed solubility parameters across standard organic solvents and aqueous buffers are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

While Eluxadoline acts locally and has limited systemic absorption, it remains a highly active pharmacological compound targeting opioid receptors. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent degradation and maintain structural integrity.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or powered air-purifying respirators (PAPR), chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, milling, and compounding stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure weighing booths to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.